|
|
News for:
|
|
For this drug, our server compiled this detailed Chemical Profile.
You will land on a page at the National Library of Medicine where you can drill down to consumer info, research citations, product labelling, toxicology and more. FindingHealthOnline is the world's leading health-pharma search portal and decision engine. It helps you drill down to very detailed information without interference from commercial sites that now dominate Bing, Google, and Yahoo. Near the top of our pages, you will find a link to content that best matches your query.
|
|
|
|
Click the Chemical Profile link above for detailed information.
Visit Betterchem's Drug Index for
- Exclusivity
Patents and market exclusivity
- Drug Information
Prescribing and other
information
- DMFs
Type 2 drug master files
- Databases
Free access to database search
- 21 CFR
FDA regulations for this drug
- Federal Register
FR search results for this drug
- Drug Recalls
For Rx's using this API
|
|
|
| |
FDA Approval Activities for this Drug
Zoloft (sertraline hydrochloride) Tablets & Concentrate, Pfizer, NDA 19-839/S045 & 20-990/S011 2/7/03 2/12/03 2/13/03
Zoloft (sertraline hydrochloride) Tablets & Concentrate, Pfizer NDA 19-839/S44 & 20-990/S10 9/16/03 9/25/03 9/25/03
Zoloft (sertraline hydrochloride) Tablets & Concentrate, Pfizer NDA 19-839/S043 & 20-990/S009 9/18/02 9/20/02
Zoloft (sertraline) Tablets & Concentrate, Pfizer NDA 19-839/S039 & 20-990/S007 5/16/02 5/21/02 5/16/02
Zoloft Indication: PMDD (Premenstrual Dysphoric Disorder).
Zoloft (sertraline hydrochloride) Tablets & Concentrate, Pfizer NDA 19-839/S036 & 20-990/S004 9/20/02 9/27/02
Zoloft (sertraline hydrochloride) Tablets & Concentrate Pfizer NDA 19-839/S035 & 20-990/S003 8/17/01 11/6/01 11/7/01 11/7/01
Zoloft (sertraline hydrochloride) Tablets & Concentrate Pfizer NDA 20-990/S-001& S002 9/26/02 7/23/03
Zoloft (sertraline hydrochloride) Tablets & Concentrate Pfizer NDA 19-839/S033 & 20-990/S-001 10/12/01 7/31/03 04/25/03
Zoloft (sertraline hydrochloride) Tablets Pfizer NDA 19-839/S026 12/7/99 7/26/01
Zoloft (sertraline hydrochloride) oral concentrate, 20 mg/ml Pfizer NDA 20-990 12/7/99 12/28/99 12/28/99 5/29/01
Zoloft indication: depression, OCD, and panic disorder. Sertraline Hydrochloride Tablets, Genpharm, Sertraline HCI Tabs, Mylan Pharmaceuticals, Zoloft (sertraline hydrochloride) oral concentrate, Pfizer Pharmaceuticals, Labeling Revision & Efficacy Supplement with Clinical Data to Support
Zoloft (sertraline hydrochloride) tablets, Pfizer Pharmaceuticals, Labeling Revision & Efficacy Supplement with Clinical Data to Support | Sertraline Hydrochloride Tablets, Ivax Pharmaceuticals, Tentative Approval | Zoloft (sertraline hydrochloride) tablets, Pfizer Pharma, Labeling Revision
| Zoloft (sertraline hydrochloride)oral concentrate, Pfizer Pharma, Labeling Revision | Sertraline Hydrochloride Tablets, Roxane Labs, Tentative Approval | Sertraline Hydrochloride Tablets, Andrx Pharma, Tentative Approval | Zoloft (sertraline hydrochloride) tablets, Pfizer Pharma, Labeling Revision | Zoloft (sertraline hydrochloride) oral concentrate, Pfizer Pharma, Labeling Revision | Sertraline Hydrochloride, Tablets, Aurobindo Pharma Limited, Inc., Tentative Approval | Sertraline Hydrochloride Tablets, Purepac Pharma, Tentative Approval | Sertraline Hydrochloride Tablets, Dr. Reddy’s Labs, Tentative Approval | Sertraline Hydrochloride Tablets, Pliva, Tentative Approval | Sertraline Hydrochloride Oral Concentrate, Roxane Labs, Tentative Approval | Sertraline Hydrochloride Tablets, InvaGen Pharma, Tentative Approval | Sertraline Hydrochloride Tablets, Zydus Pharma, Tentative Approval | Zoloft (sertraline hydrochloride) tablets, Pfizer Inc., Labeling Revision | Zoloft (sertraline hydrochloride) oral concentrate, Pfizer Inc., Labeling Revision | Sertraline Hydrochloride Tablets, InvaGen Pharma, Tentative Approval | Sertraline Hydrochloride Tablets, Mutual Pharma, Tentative Approval | Sertraline Hydrochloride Tablets, Teva Pharma, Approval | Sertraline Hydrochloride, Sandoz, Tentative Approval | Zoloft (sertraline hydrochloride) tablets, Pfizer Pharma, Labeling Revision | Zoloft (sertraline hydrochloride) oral concentrate, Pfizer Pharma, Labeling Revision | Sertraline Hydrochloride Tablets, Apotex Inc., Tentative Approval | Sertraline Hydrochloride Oral Concentrate, Ranbaxy, Tentative Approval | Sertraline Hydrochloride Tablets, Lupin Ltd., Tentative Approval | Sertraline Hydrochloride Tablets, Watson Labs, Tentative Approval | Sertraline Hydrochloride Tablets, Sun Pharma, Tentative Approval | Sertraline Hydrochloride Oral Concentrate, Ranbaxy Inc., Approval | Sertraline Hydrochloride Tablets, Sandoz Inc., Approval | Sertraline Hydrochloride Tablets, Barr Labs, Approval | Sertraline Hydrochloride Tablets, Cobalt Pharma, Approval | Sertraline Hydrochloride Tablets, Sun Pharma, Approval | Sertraline Hydrochloride Tablets, Zydus Pharma, Approval | Sertraline Hydrochloride Tablets, Mutual Pharma, Approval | Sertraline Hydrochloride Tablets, Myland Pharma, Approval | Sertraline Hydrochloride Tablets, Aurobindo Pharma, Approval | Sertraline Hydrochloride Tablets, Apotex Inc., Approval | Sertraline Hydrochloride Tablets, Actavis Elizabeth, Approval | Sertraline Hydrochloride Tablets, InvaGen Pharma, Approval | Sertraline Hydrochloride Tablets, Ranbaxy Inc., Approval | Sertraline Hydrochloride Tablets, Lupin Ltd., Approval | Sertraline Hydrochloride Tablets, Watson Labs, Approval | Sertraline Hydrochloride Tablets, Roxane Labs, Approval
Visit Betterchem's Drug Index for FDA's latest approval information.
|
|